New York State Common Retirement Fund’s Avidity Biosciences RNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.73M | Hold |
272,279
| – | – | 0.01% | 870 |
|
|
2025
Q1 | $8.04M | Buy |
272,279
+87,468
| +47% | +$2.58M | 0.01% | 813 |
|
|
2024
Q4 | $5.37M | Buy |
184,811
+598
| +0.3% | +$17.4K | 0.01% | 1072 |
|
|
2024
Q3 | $8.46M | Buy |
184,213
+63,843
| +53% | +$2.93M | 0.01% | 865 |
|
|
2024
Q2 | $4.92M | Sell |
120,370
-863
| -0.7% | -$35.3K | 0.01% | 1135 |
|
|
2024
Q1 | $3.09M | Buy |
121,233
+16,228
| +15% | +$414K | ﹤0.01% | 1300 |
|
|
2023
Q4 | $950K | Sell |
105,005
-144
| -0.1% | -$1.3K | ﹤0.01% | 1818 |
|
|
2023
Q3 | $671K | Buy |
105,149
+261
| +0.2% | +$1.67K | ﹤0.01% | 1935 |
|
|
2023
Q2 | $1.16M | Sell |
104,888
-43
| -0% | -$477 | ﹤0.01% | 1702 |
|
|
2023
Q1 | $1.61M | Buy |
104,931
+20,337
| +24% | +$312K | ﹤0.01% | 1641 |
|
|
2022
Q4 | $1.88M | Buy |
84,594
+34,857
| +70% | +$773K | ﹤0.01% | 1674 |
|
|
2022
Q3 | $812K | Buy |
49,737
+165
| +0.3% | +$2.69K | ﹤0.01% | 2073 |
|
|
2022
Q2 | $720K | Buy |
49,572
+21,240
| +75% | +$308K | ﹤0.01% | 2179 |
|
|
2022
Q1 | $523K | Buy |
28,332
+9
| +0% | +$166 | ﹤0.01% | 2389 |
|
|
2021
Q4 | $673K | Buy |
28,323
+4,712
| +20% | +$112K | ﹤0.01% | 2282 |
|
|
2021
Q3 | $582K | Sell |
23,611
-4,041
| -15% | -$99.6K | ﹤0.01% | 2378 |
|
|
2021
Q2 | $683K | Buy |
27,652
+4,752
| +21% | +$117K | ﹤0.01% | 2414 |
|
|
2021
Q1 | $499K | Buy |
22,900
+7,700
| +51% | +$168K | ﹤0.01% | 2463 |
|
|
2020
Q4 | $388K | Buy |
15,200
+7,600
| +100% | +$194K | ﹤0.01% | 2472 |
|
|
2020
Q3 | $214K | Buy |
+7,600
| New | +$214K | ﹤0.01% | 2613 |
|